Refractory Urticarial Vasculitis Responsive to Methotrexate: Could It Be a New Treatment Option?
Refractory Urticarial Vasculitis Responsive to Methotrexate: Could It Be a New Treatment Option?
Objective: Urticarial vasculitis is a chronic clinicopathologic entity characterized by clinically characterized urticarial rash, histopathologically
___
- [1] Davis MDP, van der Hilst JCH. Mimickers of Urticaria: Urticarial
Vasculitis and Autoinflammatory Diseases. J Allergy Clin
Immunol Pract 2018;6(4):1162-70.
- [2] Sjöwall C, Mandl T, Skattum L, Olsson M, Mohammad AJ.
Epidemiology of hypocomplementaemic urticarial vasculitis
(anti-C1q vasculitis). Rheumatology (Oxford) 2018; 57(8):1400-
07.
- [3] Kavala M, Türkoğlu Z, Özlü E. Metotreksat ve dermatolojide
klinik kullanımları. Med Med J 2014; 29:104-110.
- [4] Sunderkötter C, De Groot K. Therapie von Vaskulitiden und
Vaskulopathien. Der Hautarzt 2008; 59:382.
- [5] Fiorentino DF. Cutaneous vasculitis. J Am Acad Dermatol 2003;
48:311-40.
- [6] Polat AK, Belli AA, Karakus V, Dere Y. Deferasirox-induced
urticarial vasculitis in a patient with myelodysplastic syndrome.
An Bras Dermatol 2017; 92:59-61.
- [7] Black AK. Urticarial vasculitis. Clinics in Dermatology 1999;
17:565-69.
- [8] Katsambas A, Riga P. Purpura and vasculitis: unapproved
treatments. Clin Dermatol 2002; 20:626-33.
- [9] Khasnis A, Langford CA. Update on vasculitis. J Allergy Clin
Immunol 2009; 123:1226-36.
- [10] 1Shen S, O’Brien T, Yap LM, Prince HM, McCormack CJ. The
use of methotrexate in dermatology: a review. Australas J
Dermatol 2012; 53:1-18.
- [11] Thomas-Golbanov C, Sridharan S. Novel therapies in vasculitis.
Expert Opin Investig Drugs 2001; 10:1279-89.
- [12] Stack PS. Methotrexate for urticarial vasculitis. Ann Allergy
1994; 72:36-38.
- [13] Perez A, Woods A, Grattan CEH. Methotrexate: a useful steroidsparing
agent in recalcitrant chronic urticaria. Br J Dermatol
2010; 162:191-94.
- [14] Krause D, Schleusser B, Herborn G, Rau R. Response to
methotrexate treatment is associated with reduced mortality
in patients with severe rheumatoid arthritis. Arthritis Rheum
2000; 43:14-21.
- [15] Cipriani P, Ruscitti P, Carubbi F, Liakouli V, Giacomelli R.
Methotrexate: an old new drug in autoimmune disease. Expert
Review of Clinical Immunology 2014; 10:1519-30.